Pegylated Dickeya Chrysanthemi L-asparaginase

Pegylated Dickeya Chrysanthemi L-asparaginase Uses, Dosage, Side Effects, Food Interaction and all others data.

Pegylated Dickeya Chrysanthemi L-asparaginase is under investigation in clinical trial NCT02257684 (A Dose Confirmation and Pharmacokinetic Study of Pegylated Dickeya Chrysanthemi L-asparaginase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)).

Trade Name	Pegylated Dickeya Chrysanthemi L-asparaginase
Generic	Pegcrisantaspase
Pegcrisantaspase Other Names	Asparec, Mpeg-r-crisantaspase, Pegcrisantaspase, Pegylated dickeya chrysanthemi l-asparaginase, Pegylated erwinia chrysanthemi l-asparaginase
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Innovators Monograph

You find simplified version here Pegylated Dickeya Chrysanthemi L-asparaginase